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Background: The American College of Obstetrics and Gynecology (ACOG) recommends the Tdap vaccine during 27-36
weeks of pregnancy protect the neonate from pertussis between birth and their first DTaP vaccine. Nationally the rate of
Tdap vaccination in pregnant women is 48-55% with lower rates for women of color, uninsured, and non-English
speakers. The Maternity and Family Planning (MFP) clinics at UNM are a federally funded clinics that provide
comprehensive prenatal and postnatal care for women, especially low-income and/or at-risk pregnant women. The MFP
clinics at UNM do not have Tdap vaccines on site and refer women to the Department of Health (DOH) for the vaccine.
This goal of this project is to determine if this referral approach has been as effective as having vaccines on site as is the
case in the University-based obstetrical clinics.
Methods: The study utilized a retrospective electronic health record chart review to compare rates of antepartum Tdap
vaccination of patients from the MPF clinics to the patients from the University-based obstetrical clinics. The list of patients
were crossed checked in New Mexico Statewide Immunization Information System (NMSIIS) to ensure records of DOH
vaccines were captured. A two-sample proportion z test was utilized to test for statistical significance in rates. Logistic
regression was also utilized to find other significant predictive factors for receiving the vaccine.
Results: Preliminary results of 237 charts reviewed show that there was a significant difference in the rates of Tdap
during pregnancy for MFP (N=66) and obstetrical clinics (N=171) at 21.2% and 70.07%, respectively (p<.0001). Logistic
regression models showed increased odds of a patient receiving Tdap in pregnancy with receiving prenatal care at only
obstetrical clinics, increased prenatal visits, and being categorized as Non-Hispanic White (odds ratio 19.25, P<.000;
1.13, P<.003; 2.26, P<.027, respectively).
Conclusion: UNM obstetric clinics that offer Tdap on site have a much higher rate of Tdap during pregnancy than MFP
clinics that refer patients to DOH. Possible interventions aimed at improving this disparity in rates may include offering
vaccines on site, close tracking and follow up patient’s vaccination status after DOH referral, and/or patient and staff
education.

